1. Role of Stromal Expression of CD34 Immunohistochemical Marker in Proliferative Lesions of Breast: a Diagnostic Study at a Tertiary Care Center in Western Rajasthan.
- Author
-
Kumar, Bhageerath, Joshee, Rajni, khatri, Kishore kumar, Anita, Kumari, Rama, and chouhan, Omveer Singh
- Subjects
PHYLLODES tumors ,CD34 antigen ,HEMATOXYLIN & eosin staining ,IMMUNOSTAINING ,TERTIARY care ,STROMAL cells - Abstract
Introduction: CD34 antigen is a tool important in differentiating between benign and malignant conditions. This study was aimed to determine the stromal expression of CD34 antigen by immunohistochemical method in proliferative lesions of the breast and to evaluate the specificity of loss of CD34 antigen expression in stromal cells for malignant lesions. Materials and methods: 90 cases of proliferative lesions of the breast were studied from January 2022 to December 2022. Paraffin-embedded blocks were retrieved for all the cases and underwent routine processing followed by Hematoxylin and Eosin staining. 54 cases of the benign lesion and 36 cases of the malignant lesion were studied for CD34 immunohistochemical staining, and semi-quantitative assessment was done. Results: Out of total 35 cases having grade-0 expression, majority are Infiltrating Duct Carcinoma (19 cases) followed by Invasive Breast Carcinoma (13 cases, small biopsies). We had 1 cases of grade-1 expression and it was Complex Fibroadenoma. Out of 14 cases having grade-2 expression, majority were fibroadenoma (6 cases) followed by 2 cases of tubular adenoma, 1 case each of benign phylloides, borderline phyllodes tumor, fibroadenosis, fibroadeomatoid hyperplasia, fibroadenoma with apocrine changes and fibroadenoma with epithelial hyperplasia. Out of 40 cases having grade-3 expression, majority were fibroadenomas (29 cases) followed by 3 cases each of fibroadenoma with fibrocystic disease and fibroadenoma with epithelial hyperplasia, 2 case each of fibrocystic disease and fibroadenoma with apocrine changes and 1 case of epithelial hyperplasia. Conclusion: CD34 antigen expression in stromal cells can be used as an adjuvant tool in differentiating between benign and malignant conditions where the morphology is equivocal. [ABSTRACT FROM AUTHOR]
- Published
- 2023